 Tiziana Life Sciences PLC NASDAQ:TLSA, LON:TILS said it plans to list its diagnostics business Accustem Sciences on the Nasdaq stock market in the US after its demerger and the distribution of new stock to Tiziana shareholders. The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustems business, a short statement read. 